EUVIMEDEUVIMED entdecken
Crossref

Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy

Huijuan Song, Qi Su, Yu Nie, Chuangnian Zhang, Pingsheng Huang, Shengbin Shi, Qiang Liu, Weiwei Wang

Acta Biomaterialia · 2023-03 · 158 · 535-546

DOI: 10.1016/j.actbio.2022.12.070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023-03. Verfasst von Huijuan Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, Neoplasms, Vaccines, Subunit. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Science Fund for Distinguished Young Scholars of Tianjin, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccination shows great promise in cancer immunotherapy. However, the induction of robust and broad therapeutic CD8 T cell immunity against tumors is challenging due to the essential heterogenicity of tumor antigen expression. Recently, bioinspired materials have reshaped the field of cancer nanomedicine. Herein, a bioinspired nanofibrous trivalent peptide hydrogel vaccine was constructed using the spontaneous supramolecular co-assembly of three antigenic epitope-conjugated peptides, which could mimic the fibrillar structure and biological function of the extracellular matrix and naturally occurring protein assembly. The hydrogel vaccine could be accurately and flexibly adjusted to load each antigenic peptide at a defined ratio, which facilitated the antigen presentation of dendritic cells and significantly improved the initiation of CD8 T cell response and the secretion of interferon-γ (IFN-γ). C57BL/6 mice were immunized with the trivalent peptide hydrogel vaccine, where it elicited a high broad-spectrum antitumor CD8 T cell response that significantly inhibited the growth of B16 tumors in the absence of additional immunoadjuvants or delivery systems. In summary, the supramolecular assembly of triple antigenic epitope-conjugated peptides offers a simple, customizable, and versatile approach for the development of cancer vaccines with remarkable therapeutic efficacy, thereby providing a highly versatile platform for the application of personalized multivalent tumor vaccines. STATEMENT OF SIGNIFICANCE: (1) We report a feasible, versatile and bioinspired approach to manufacture a multivalent peptide-based hydrogel cancer vaccine in the absence of additional adjuvants, which closely mimics immune niches, co-delivers antigen epitopes, greatly promotes antigen presentation to DCs and their subsequent homing to dLNs and elicits a broad-spectrum antitumor CD8 T cell response, resulting in significant inhibition of B16 tumor growth. (2) This feasible and efficient co-assembly strategy provides an attractive platform for engineering a range of multivalent vaccines at defined ratios to further enhance antigen-specific T cell responses. This approach may also be used for personalized immunotherapy with neo-epitopes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesImmunotherapyNeoplasmsVaccines, SubunitAnimalsMiceAdjuvants, ImmunologicAntigens, NeoplasmCD8-Positive T-LymphocytesDendritic CellsEpitopesHydrogelsMice, Inbred C57BLPeptides

Stichwörter der Autor:innen

Bioinspired hydrogelCo-assemblyPeptide antigenTrivalent vaccineTumor immunotherapy

Substanzen

Adjuvants, ImmunologicAntigens, NeoplasmCancer VaccinesEpitopesHydrogelsPeptidesVaccines, Subunit

Autor:innen und Institutionen

  • Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
  • Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
  • Department of Gastrointestinal Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
  • Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China; Key Laboratory of Innovative Cardiovascul…
  • Department of Gastrointestinal Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China. Electronic address: sbshi@sdfmu…
  • Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China. Electronic address: liuqiang@irm-cams.ac.cn.

Förderung

  • Fundamental Research Funds for the Central Universities
  • Science Fund for Distinguished Young Scholars of Tianjin
  • National Natural Science Foundation of China

Zitieren

APA

Song, H., Su, Q., Nie, Y., Zhang, C., Huang, P., Shi, S., Liu, Q., & Wang, W. (2023). Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy. Acta Biomaterialia, 158, 535-546. https://doi.org/10.1016/j.actbio.2022.12.070

Vancouver

Song H, Su Q, Nie Y, Zhang C, Huang P, Shi S, et al. Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy. Acta Biomaterialia. 2023;158:535-546. doi:10.1016/j.actbio.2022.12.070

BibTeX
@article{Song2023,
  author = {Song, Huijuan and Su, Qi and Nie, Yu and Zhang, Chuangnian and Huang, Pingsheng and Shi, Shengbin and Liu, Qiang and Wang, Weiwei},
  title = {Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy},
  journal = {Acta Biomaterialia},
  year = {2023},
  volume = {158},
  pages = {535--546},
  doi = {10.1016/j.actbio.2022.12.070}
}
Kostenlos starten →